Goldman Sachs’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$151M Buy
1,255,800
+471,500
+60% +$54.4M 0.02% 818
2025
Q4
$82.6M Buy
784,300
+684,400
+685% +$64.2M 0.01% 1129
2025
Q3
$8.38M Sell
99,900
-86,000
-46% -$7.08M ﹤0.01% 3143
2025
Q2
$14.7M Buy
185,900
+124,100
+201% +$9.86M ﹤0.01% 2396
2025
Q1
$5.55M Sell
61,800
-5,400
-8% -$504K ﹤0.01% 3249
2024
Q4
$6.69M Sell
67,200
-255,600
-79% -$26.4M ﹤0.01% 3171
2024
Q3
$36.7M Buy
322,800
+114,900
+55% +$13.7M 0.01% 1508
2024
Q2
$25.7M Sell
207,900
-95,900
-32% -$12.4M ﹤0.01% 1683
2024
Q1
$40.1M Sell
303,800
-41,600
-12% -$5.13M 0.01% 1304
2023
Q4
$37.7M Buy
345,400
+122,900
+55% +$12.8M 0.01% 1384
2023
Q3
$22.9M Buy
222,500
+113,200
+104% +$12.2M ﹤0.01% 1665
2023
Q2
$12.6M Sell
109,300
-15,400
-12% -$1.75M ﹤0.01% 2232
2023
Q1
$13.3M Sell
124,700
-259,600
-68% -$28M ﹤0.01% 2168
2022
Q4
$42.6M Sell
384,300
-300,000
-44% -$30.7M 0.01% 1303
2022
Q3
$58.9M Sell
684,300
-209,500
-23% -$18.7M 0.01% 1005
2022
Q2
$81.5M Sell
893,800
-3,500
-0.4% -$310K 0.02% 811
2022
Q1
$73.6M Buy
897,300
+54,600
+6% +$4.3M 0.02% 971
2021
Q4
$64.6M Buy
842,700
+458,600
+119% +$36.5M 0.01% 1134
2021
Q3
$28.9M Buy
384,100
+80,900
+27% +$6.15M 0.01% 1725
2021
Q2
$23.6M Buy
303,200
+187,186
+161% +$13.9M 0.01% 1900
2021
Q1
$8.53M Sell
116,014
-20,960
-15% -$1.55M ﹤0.01% 2694
2020
Q4
$10.7M Buy
136,974
+23,371
+21% +$1.79M ﹤0.01% 2396
2020
Q3
$8.99M Buy
113,603
+11,423
+11% +$895K ﹤0.01% 2420
2020
Q2
$7.54M Sell
102,180
-284,742
-74% -$21.4M ﹤0.01% 2468
2020
Q1
$28.4M Sell
386,922
-338,294
-47% -$26.6M 0.01% 1255
2019
Q4
$62.9M Sell
725,216
-452,422
-38% -$37.2M 0.02% 984
2019
Q3
$94.6M Buy
1,177,638
+607,107
+106% +$48.7M 0.03% 690
2019
Q2
$45.6M Sell
570,531
-280,864
-33% -$21.5M 0.01% 1195
2019
Q1
$67.6M Sell
851,395
-376,442
-31% -$28.2M 0.02% 903
2018
Q4
$89.5M Buy
1,227,837
+467,723
+62% +$33M 0.03% 672
2018
Q3
$51.5M Sell
760,114
-798,367
-51% -$50.9M 0.01% 1199
2018
Q2
$90.3M Buy
1,558,481
+445,400
+40% +$25.1M 0.02% 816
2018
Q1
$57.9M Buy
1,113,081
+33,851
+3% +$1.83M 0.01% 1108
2017
Q4
$57.9M Buy
1,079,230
+148,082
+16% +$8.21M 0.01% 1183
2017
Q3
$56.9M Buy
931,148
+151,541
+19% +$9.19M 0.01% 1185
2017
Q2
$47.7M Buy
779,607
+89,813
+13% +$5.47M 0.01% 1268
2017
Q1
$41.8M Sell
689,794
-885,769
-56% -$53.7M 0.01% 1343
2016
Q4
$88.5M Sell
1,575,563
-132,887
-8% -$7.78M 0.03% 858
2016
Q3
$102M Sell
1,708,450
-1,261,896
-42% -$73.8M 0.03% 704
2016
Q2
$163M Buy
2,970,346
+1,684,974
+131% +$89.7M 0.05% 431
2016
Q1
$64.9M Sell
1,285,372
-1,198,807
-48% -$58.7M 0.02% 908
2015
Q4
$125M Sell
2,484,179
-597,779
-19% -$30.1M 0.04% 542
2015
Q3
$145M Buy
3,081,958
+1,412,808
+85% +$75.1M 0.05% 439
2015
Q2
$90.7M Buy
1,669,150
+533,642
+47% +$29.9M 0.03% 717
2015
Q1
$62.3M Sell
1,135,508
-300,252
-21% -$17M 0.02% 933
2014
Q4
$77.8M Buy
1,435,760
+454,727
+46% +$25.3M 0.02% 811
2014
Q3
$55.5M Sell
981,033
-461,644
-32% -$25.9M 0.02% 993
2014
Q2
$79.6M Sell
1,442,677
-415,846
-22% -$22.7M 0.03% 795
2014
Q1
$101M Sell
1,858,523
-1,916,478
-51% -$99.2M 0.03% 617
2013
Q4
$180M Buy
3,775,001
+2,185,604
+138% +$99.9M 0.06% 382
2013
Q3
$72.2M Sell
1,589,397
-1,904,635
-55% -$87M 0.03% 744
2013
Q2
$155M Buy
+3,494,032
New +$156M 0.06% 363

Other funds holding MRK

Goldman Sachs's MRK Position: Q1 2026 in Review

Goldman Sachs increased its Merck (MRK) stake by 4.1% in Q1 2026, buying an estimated $90.6M and bringing the position to 20,133,379 shares worth $2.42B. The position accounts for 0.28% of the portfolio, ranked #50.

Goldman Sachs first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Goldman Sachs held 20,133,379 shares of Merck worth $2.42B as of Q1 2026.
  • Goldman Sachs bought 784,661 Merck shares in Q1 2026, an estimated $90.6M.
  • Merck made up 0.28% of Goldman Sachs's portfolio in Q1 2026, its #50 holding.
  • Goldman Sachs first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.